Science 37 Holdings, Inc.
SNCEDelisted Mar 12, 2024- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001819113
Science 37 Holdings, Inc. was delisted on Mar 12, 2024; its insiders filed their last Form 4 on Mar 14, 2024; 29 institutions reported holding it in 13F filings for Q4 2023, worth $13.3M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 2:27 PM ET
Revenue flow, FY2022
Where the revenue went in FY2022, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2022: $51.0M (72.7% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Jun 30, 2021 |
| Filing | 10-K | 10-K | 10-K/A |
| Reported | Mar 6, 2023 | Mar 22, 2022 | – |
| Revenue | $70.1M | $59.6M | – |
| Selling, general and administrative | $103.3M | $73.1M | – |
| Operating income | -$152.0M | -$63.7M | -$591.8K |
| Income tax | -$90.0K | $1.00K | – |
| Net income | -$51.0M | -$94.3M | -$561.4K |
| EPS, basic | $-0.44 | $-2.89 | $-0.08 |
| EPS, diluted | $-0.44 | $-2.89 | $-0.08 |
| Weighted shares, basic | 115.9M | 32.7M | 6.73M |
| Weighted shares, diluted | 115.9M | 32.7M | 6.73M |
| Margins and growth | |||
| Operating margin | -216.7% | -106.9% | – |
| Net margin | -72.7% | -158.3% | – |
| Revenue growth, year over year | +17.7% | – | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2022 | FY2021 | FY2020! |
|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Jun 30, 2021 |
| Filing | 10-K | 10-K | 10-K/A |
| Reported | Mar 6, 2023 | Mar 22, 2022 | – |
| Cash and equivalents | $108.1M | $214.6M | $416.1K |
| Total current assets | $126.2M | $232.7M | $537.3K |
| Property, plant and equipment | $0 | $1.39M | – |
| Total assets | $126.4M | $260.8M | $80.7M |
| Accounts payable | $7.21M | $12.8M | – |
| Total current liabilities | $23.2M | $35.0M | – |
| Total liabilities | $29.1M | $139.2M | $131.8K |
| Shareholders' equity | $97.4M | $121.6M | $435.9K |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2022 | FY2021 | FY2020 |
|---|---|---|---|
| Period end | Dec 31, 2022 | Dec 31, 2021 | Jun 30, 2021 |
| Filing | 10-K | 10-K | 10-K/A |
| Reported | Mar 6, 2023 | Mar 22, 2022 | – |
| Operating cash flow | -$75.4M | -$36.5M | -$582.2K |
| Capital expenditures | $167.0K | $1.23M | – |
| Free cash flow | -$75.6M | -$37.7M | – |
| Depreciation and amortization | $17.9M | $7.80M | – |
| Stock-based compensation | $24.6M | $8.41M | – |
| Share buybacks | – | $0 | – |
| Investing cash flow | -$31.9M | -$20.6M | -$80.1M |
| Financing cash flow | $610.0K | $238.2M | $81.1M |
| Net change in cash | -$106.5M | $181.1M | $391.1K |
| Ratio | |||
| Stock-based compensation, % of revenue | 35.0% | 14.1% | – |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Nov 2, 2023 | 119.4M | +2.3% | SEC |
| Aug 2, 2023 | 117.1M | +0.7% | SEC |
| May 9, 2023 | 116.8M | +0.7% | SEC |
| Mar 1, 2023 | 116.7M | +1.1% | SEC |
| Nov 4, 2022 | 116.7M | +1,065.3% | SEC |
| Aug 4, 2022 | 116.3M | +1,062.2% | SEC |
| May 2, 2022 | 116.0M | +1,058.7% | SEC |
| Mar 14, 2022 | 115.5M | +1,053.6% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Jun 30, 2020, from 13F share counts: 1-for-20 in Q4 2023.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.